The rationale for testing drug combinations in aging intervention studies
Aging Pathobiology and Therapeutics · 2019
DOI: 10.31491/apt.2019.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, 2019. Verfasst von Kavita Sharma und 8 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharma, K., Wang, J., Jiang, Z., Klug, J., Darvas, M., Imai, D. M., Snider, T., Niedernhofer, L., & Ladiges, W. (2019). The rationale for testing drug combinations in aging intervention studies. Aging Pathobiology and Therapeutics. https://doi.org/10.31491/apt.2019.12.001
Vancouver
Sharma K, Wang J, Jiang Z, Klug J, Darvas M, Imai DM, et al. The rationale for testing drug combinations in aging intervention studies. Aging Pathobiology and Therapeutics. 2019. doi:10.31491/apt.2019.12.001
BibTeX
@article{Sharma2019,
author = {Sharma, Kavita and Wang, Juan and Jiang, Zhou and Klug, Jenna and Darvas, Martin and Imai, Denise M. and Snider, Timothy and Niedernhofer, Laura and Ladiges, Warren},
title = {The rationale for testing drug combinations in aging intervention studies},
journal = {Aging Pathobiology and Therapeutics},
year = {2019},
doi = {10.31491/apt.2019.12.001}
}
EUVIMED